Cancel
About Francesco Galimi
Francesco Galimi serves as the Chief Medical Officer at Adicet, bringing extensive experience in medical oncology and clinical development from prestigious roles at Amgen, Inc., Onyx Pharmaceuticals, and GNF/Novartis.
Known information
Francesco Galimi is the Chief Medical Officer at Adicet, where he has been since September 2019. He holds an M.D. and a Ph.D. from the University of Torino Medical School, with a specialty certification in Medical Oncology. Prior to joining Adicet, Galimi served as the Global Program General Manager, Early Development at Amgen, Inc., and was the Head of Clinical Development at Onyx Pharmaceuticals, Inc. Additionally, he held significant leadership roles at GNF/Novartis, where he led the early development of a portfolio of oncology programs. His extensive background in medical oncology and clinical development has positioned him as a key leader in the field.
About Adicet Bio
Adicet Bio is a biotechnology company specializing in the development of allogeneic, genetically modified gamma delta T cells for treating autoimmune diseases and cancer, with offices in Redwood City, CA, and Boston, MA.
Report inaccurate information
